Target intelligence / Profile preview

Intestinal barrier epithelial cell (IEC)

Target
IEC
Molecular classification
Other (cell population including specialized subtypes, not a classical molecular target)
01

Overview

Intestinal barrier epithelial cells comprise a monolayer of specialized cell types—**enterocytes**, **goblet cells**, **Paneth cells**, **tuft cells**, and microfold cells—forming the gut lining that separates the lumen from underlying tissue. Their principal role is to control nutrient absorption and fluid transport, protect against pathogens and toxins through the barrier and mucosal defense mechanisms, and regulate local immune responses in concert with immune and stromal cells. These cells are rapidly renewed from stem cells in the crypts (turnover every 2-7 days)[2][4]. Tight junctions and other intercellular adhesion structures are critical for maintaining barrier integrity[1][3][5]. Disruption of this barrier is implicated in inflammatory bowel diseases, colorectal cancer, and infection[1]. Note: This is a cellular/tissue-level term, not a classical therapeutic target such as a receptor or enzyme; for specific drug targets in this system, refer to *tight junction proteins*, *MUC2*, *α-defensin*, or signaling pathways such as WNT, or individual cell types' surface molecules.

Other names
Intestinal epithelial cellIECGut epithelial cell
02

Biological functions

Barrier functionRegulation of permeabilityAbsorption of nutrientsImmune defenseRenewal/regenerationInteraction with gut microbiota
03

Disease associations

Inflammation (inflammatory bowel disease, colitis)Cancer (colorectal cancer)Infection (susceptibility to enteric pathogens)Other (contributes to metabolic disease, food allergy pathogenesis)
04

Safety considerations

Barrier disruption can lead to pathogen invasion, chronic inflammation, and increased cancer riskTherapeutic attempts to modulate barrier may result in unintended increased permeability (“leaky gut”), infection, or autoimmune responses
05

Biomarkers

Tight junction proteins (e.g., occludin, claudins, zonula occludens/ZOs)Mucin (e.g., MUC2 for goblet cells)α-defensin (Paneth cells)

Beyond the preview

Go deeper on Intestinal barrier epithelial cell (IEC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal barrier epithelial cell (IEC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call